PRostate Olaparib Real World Evidence Study

Clinical trial NCT06031805 · RECRUITING

Trial details

NCT number: NCT06031805
Sponsor: AstraZeneca
Status: RECRUITING
Study type: OBSERVATIONAL

Metastatic Castration-resistant Prostate Cancer

Start date: 2023-10-11
Primary completion: 2028-10-13
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.